Literature DB >> 30802357

Conformational analysis of apolipoprotein E3/E4 heteromerization.

Kai-Han Tu1, Devan Abhari1, Vasanthy Narayanaswami1.   

Abstract

Apolipoprotein E (apoE) is a 299 residue, exchangeable apolipoprotein that has essential roles in cholesterol homeostasis and reverse cholesterol transport. It is a two-domain protein with the C-terminal (CT) domain mediating protein self-association via helix-helix interactions. In humans, the APOE gene is polymorphic with three common alleles, ε2, ε3, and ε4, occurring in frequencies of ~ 5%, 77%, and 18%, respectively. Heterozygotes expressing apoE3 and apoE4 isoforms, which differ in residue at position 112 in the N-terminal domain (C112 in apoE3 and R112 in apoE4), represent the highest population of ε4 carriers, an allele highly associated with Alzheimer's disease. The objective of this study was to determine if apoE3 and apoE4 have the ability to hybridize to form a heteromer in lipid-free state. Refolding an equimolar mixture of His-apoE3 and FLAG-apoE4 (or vice versa) followed by pull-down and immunoblotting indicated formation of apoE3/apoE4 heteromers. Förster resonance energy transfer between donor fluorophore on one isoform and acceptor on the other, both located in the respective CT domains, revealed a distance of separation of ~ 46 Å between the donor/acceptor pair. Similarly, a quencher placed on one was able to mediate significant quenching of fluorescence emission on the other, indicative of spatial proximity within collisional distance between the two. ApoE3/apoE4 heteromer association was also noted in lipid-associated state in reconstituted lipoprotein particles. The possibility of heteromerization of apoE3/apoE4 bears implications in the potential mitigating role of apoE3 on the folding and physiological behavior of apoE4 and its role in maintaining cholesterol homeostasis.
© 2019 Federation of European Biochemical Societies.

Entities:  

Keywords:  zzm321990FRETzzm321990; apolipoprotein E3; apolipoprotein E4; heteromerization; lipoproteins

Mesh:

Substances:

Year:  2019        PMID: 30802357      PMCID: PMC6733585          DOI: 10.1111/febs.14794

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  54 in total

Review 1.  Diverse roles for the LDL receptor family.

Authors:  Dudley K Strickland; Steven L Gonias; W Scott Argraves
Journal:  Trends Endocrinol Metab       Date:  2002-03       Impact factor: 12.015

2.  Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain.

Authors:  J A Morrow; M L Segall; S Lund-Katz; M C Phillips; M Knapp; B Rupp; K H Weisgraber
Journal:  Biochemistry       Date:  2000-09-26       Impact factor: 3.162

3.  Effect of arginine 172 on the binding of apolipoprotein E to the low density lipoprotein receptor.

Authors:  J A Morrow; K S Arnold; J Dong; M E Balestra; T L Innerarity; K H Weisgraber
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

4.  Self-association of human apolipoprotein E3 and E4 in the presence and absence of phospholipid.

Authors:  M A Perugini; P Schuck; G J Howlett
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

5.  ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte-derived macrophages.

Authors:  A Von Eckardstein; C Langer; T Engel; I Schaukal; A Cignarella; J Reinhardt; S Lorkowski; Z Li; X Zhou; P Cullen; G Assmann
Journal:  FASEB J       Date:  2001-07       Impact factor: 5.191

Review 6.  Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses.

Authors:  A M Saunders
Journal:  J Neuropathol Exp Neurol       Date:  2000-09       Impact factor: 3.685

7.  Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes.

Authors:  C D Mamotte; M Sturm; J I Foo; F M van Bockxmeer; R R Taylor
Journal:  Am J Physiol       Date:  1999-03

Review 8.  The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms.

Authors:  C E Finch; R M Sapolsky
Journal:  Neurobiol Aging       Date:  1999 Jul-Aug       Impact factor: 4.673

Review 9.  Apolipoprotein E: far more than a lipid transport protein.

Authors:  R W Mahley; S C Rall
Journal:  Annu Rev Genomics Hum Genet       Date:  2000       Impact factor: 8.929

10.  APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.

Authors:  Hiroaki Fukumoto; Martin Ingelsson; Nina Gårevik; Lars Olof Wahlund; Nobuyuki Nukina; Yoshio Yaguchi; Masao Shibata; Bradley T Hyman; G William Rebeck; Michael C Irizarry
Journal:  Exp Neurol       Date:  2003-09       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.